EQUANOX medical nitrous oxide 50% v/v and oxygen 50% v/v gas in gas cylinder Australia - English - Department of Health (Therapeutic Goods Administration)

equanox medical nitrous oxide 50% v/v and oxygen 50% v/v gas in gas cylinder

coregas pty ltd - nitrous oxide, quantity: 50 % v/v; oxygen, quantity: 50 % v/v - gas, medicinal - excipient ingredients: - indications as at 7 november 2001: nitrous oxide with oxygen (equanox) is indicated in adults and children for analgesia.

AIR LIQUIDE AUSTRALIA LIMITED Nitronox 50% Nitrous Oxide and 50% Oxygen Mixture Gas Medicinal Australia - English - Department of Health (Therapeutic Goods Administration)

air liquide australia limited nitronox 50% nitrous oxide and 50% oxygen mixture gas medicinal

air liquide healthcare pty ltd - nitrous oxide, quantity: 0.5 l/l; oxygen, quantity: 0.5 l/l - gas, medicinal - excipient ingredients: - indications as at 31 october 2001: nitrous oxide with oxygen (nitronox) is indicated in adults and children for analgesia.

ALPHA D3 0.25 MCG Israel - English - Ministry of Health

alpha d3 0.25 mcg

teva pharmaceutical industries ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 0.25 mcg - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

ALPHA D3 0.25 MCG Israel - English - Ministry of Health

alpha d3 0.25 mcg

teva pharmaceutical industries ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 0.25 mcg - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

ALPHA D3 1.0 MCG Israel - English - Ministry of Health

alpha d3 1.0 mcg

teva pharmaceutical industries ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 1 mcg - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

BICA VERA 1.5 % GLUCOSE 1.75 MMOLL CALCIUM Israel - English - Ministry of Health

bica vera 1.5 % glucose 1.75 mmoll calcium

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; calcium chloride dihydrate; glucose monohydrate; glucose monohydrate; magnesium chloride hexahydrate; magnesium chloride hexahydrate; sodium chloride; sodium chloride; sodium hydrogen carbonate; sodium hydrogen carbonate - solution for peritoneal dialysis - sodium chloride 11.57 g/l; calcium chloride dihydrate 0.5145 g/l; magnesium chloride hexahydrate 0.2033 g/l; sodium chloride 5.786 g/l; glucose monohydrate 33.0 g/l; glucose monohydrate 16.5 g/l; magnesium chloride hexahydrate 0.1017 g/l; calcium chloride dihydrate 0.2573 g/l; sodium hydrogen carbonate 2.940 g/l; sodium hydrogen carbonate 5.880 g/l - combinations of electrolytes - end-stage (decompensated ) chronic renal failure of any origin treated with peritoneal dialysis.17/10/2017 בקשה לשינוי משטר מינון שינוי משטר מינון בהתאם למאושר באירופה

JANUET XR 1001000 MG TABLETS Israel - English - Ministry of Health

januet xr 1001000 mg tablets

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 100 mg; metformin hydrochloride 1000 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

JANUET XR 1001000 MG TABLETS Israel - English - Ministry of Health

januet xr 1001000 mg tablets

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 100 mg; metformin hydrochloride 1000 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

JANUET 50 MG1000 MG Israel - English - Ministry of Health

januet 50 mg1000 mg

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - tablets - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 1000 mg - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

JANUET 50 MG500 MG Israel - English - Ministry of Health

januet 50 mg500 mg

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - tablets - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 500 mg - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.